{"entity":{"type":"insider","cik":"0001682093","url":"/insider/0001682093","json_url":"/insider/0001682093.json","name":"OrbiMed Advisors Israel II Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":70,"n_filings":20,"first":"2017-04-27","last":"2026-04-09","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Advisors Israel II Ltd","source":"filing","n_filings":20,"first_seen":"2017-04-27","last_seen":"2026-04-09"}],"transactions":[{"id":5901684,"accession":"0000947871-26-000421","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72939.0,"shares_display":"72,939","price_per_share":6.417444576975281,"price_display":"6.42","price_state":"stated","total_value":468081.99,"total_display":"468,081.99","total_whole":"468,082","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-09","scope":"insider","n_lines":2},{"id":5901680,"accession":"0000947871-26-000421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000421","line_url":"/filing/0000947871-26-000421","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP V LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC; OrbiMed Israel BioFund GP Limited Partnership","owner_display_name":"OrbiMed Capital GP V LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31719.0,"shares_display":"31,719","price_per_share":6.5186503357609,"price_display":"6.52","price_state":"stated","total_value":206765.07,"total_display":"206,765.07","total_whole":"206,765","shares_owned_after":34923.0,"shares_owned_after_display":"34,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-09","scope":"insider","n_lines":2},{"id":4523966,"accession":"0000947871-25-000898","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000898","line_url":"/filing/0000947871-25-000898","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Capital GP V LLC; OrbiMed Israel GP II, L.P.; OrbiMed Capital GP VI LLC; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP Ltd.","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000000.0,"shares_display":"5,000,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":4490254.0,"shares_owned_after_display":"4,490,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider","n_lines":2},{"id":2886017,"accession":"0000947871-24-000806","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-24-000806","line_url":"/filing/0000947871-24-000806","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Upstream Bio, Inc.","issuer_ticker":"UPB","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VIII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VIII LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":825000.0,"shares_display":"825,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":14025000.0,"total_display":"14,025,000.00","total_whole":"14,025,000","shares_owned_after":4554873.0,"shares_owned_after_display":"4,554,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-17","scope":"insider","n_lines":2},{"id":2340772,"accession":"0000950170-24-008053","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-008053","line_url":"/filing/0000950170-24-008053","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Capital GP V LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP II, L.P.; OrbiMed Israel GP Ltd.","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3125000.0,"shares_display":"3,125,000","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":7500000.0,"total_display":"7,500,000.00","total_whole":"7,500,000","shares_owned_after":7526359.0,"shares_owned_after_display":"7,526,359","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-26","scope":"insider","n_lines":3},{"id":7857089,"accession":"0000947871-23-000873","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000873","line_url":"/filing/0000947871-23-000873","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC; OrbiMed Israel GP II, L.P.","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":822680.0,"shares_display":"822,680","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":617010.0,"total_display":"617,010.00","total_whole":"617,010","shares_owned_after":1510375.0,"shares_owned_after_display":"1,510,375","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-17","scope":"insider","n_lines":3},{"id":8575982,"accession":"0000947871-23-000809","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000809","line_url":"/filing/0000947871-23-000809","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":209400.0,"shares_display":"209,400","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":628200.0,"total_display":"628,200.00","total_whole":"628,200","shares_owned_after":2105909.0,"shares_owned_after_display":"2,105,909","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-31","filed_date":"2023-08-02","scope":"insider","n_lines":3},{"id":8352869,"accession":"0000947871-23-000789","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000789","line_url":"/filing/0000947871-23-000789","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Israel GP II, L.P.; OrbiMed Genesis GP LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39200.0,"shares_display":"39,200","price_per_share":2.92,"price_display":"2.92","price_state":"stated","total_value":114464.0,"total_display":"114,464.00","total_whole":"114,464","shares_owned_after":2258987.0,"shares_owned_after_display":"2,258,987","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-25","filed_date":"2023-07-27","scope":"insider","n_lines":3},{"id":8529572,"accession":"0000947871-23-000753","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000753","line_url":"/filing/0000947871-23-000753","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":194700.0,"shares_display":"194,700","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":467280.0,"total_display":"467,280.00","total_whole":"467,280","shares_owned_after":2285687.0,"shares_owned_after_display":"2,285,687","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-17","scope":"insider","n_lines":3},{"id":8620728,"accession":"0000947871-23-000713","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-23-000713","line_url":"/filing/0000947871-23-000713","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Israel GP II, L.P.; OrbiMed Israel BioFund GP Limited Partnership; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; Chimovits Erez; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP V LLC","owner_display_name":"OrbiMed Israel GP II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":875000.0,"shares_display":"875,000","price_per_share":2.09,"price_display":"2.09","price_state":"stated","total_value":1828750.0,"total_display":"1,828,750.00","total_whole":"1,828,750","shares_owned_after":5685259.0,"shares_owned_after_display":"5,685,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-29","scope":"insider","n_lines":4},{"id":8670455,"accession":"0000947871-23-000472","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000947871-23-000472","line_url":"/filing/0000947871-23-000472","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13089.0,"shares_display":"13,089","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":25785.33,"total_display":"25,785.33","total_whole":"25,785","shares_owned_after":2417787.0,"shares_owned_after_display":"2,417,787","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-17","scope":"insider","n_lines":3},{"id":8670446,"accession":"0000947871-23-000472","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-23-000472","line_url":"/filing/0000947871-23-000472","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41446.0,"shares_display":"41,446","price_per_share":1.86,"price_display":"1.86","price_state":"stated","total_value":77089.56,"total_display":"77,089.56","total_whole":"77,090","shares_owned_after":2426665.0,"shares_owned_after_display":"2,426,665","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-14","filed_date":"2023-04-17","scope":"insider","n_lines":3},{"id":8670437,"accession":"0000947871-23-000472","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000472","line_url":"/filing/0000947871-23-000472","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VII LLC; OrbiMed Israel GP II, L.P.; OrbiMed Advisors Israel II Ltd; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13946.0,"shares_display":"13,946","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":25381.72,"total_display":"25,381.72","total_whole":"25,382","shares_owned_after":2454775.0,"shares_owned_after_display":"2,454,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-13","filed_date":"2023-04-17","scope":"insider","n_lines":3},{"id":8620721,"accession":"0000947871-23-000452","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000947871-23-000452","line_url":"/filing/0000947871-23-000452","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2363.0,"shares_display":"2,363","price_per_share":1.81,"price_display":"1.81","price_state":"stated","total_value":4277.03,"total_display":"4,277.03","total_whole":"4,277","shares_owned_after":2464234.0,"shares_owned_after_display":"2,464,234","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-12","filed_date":"2023-04-12","scope":"insider","n_lines":3},{"id":8620715,"accession":"0000947871-23-000452","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-23-000452","line_url":"/filing/0000947871-23-000452","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13946.0,"shares_display":"13,946","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":25381.72,"total_display":"25,381.72","total_whole":"25,382","shares_owned_after":2465837.0,"shares_owned_after_display":"2,465,837","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-11","filed_date":"2023-04-12","scope":"insider","n_lines":3},{"id":8620710,"accession":"0000947871-23-000452","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000452","line_url":"/filing/0000947871-23-000452","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC; OrbiMed Israel GP II, L.P.; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51228.0,"shares_display":"51,228","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":91698.12,"total_display":"91,698.12","total_whole":"91,698","shares_owned_after":2500582.0,"shares_owned_after_display":"2,500,582","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-10","filed_date":"2023-04-12","scope":"insider","n_lines":3},{"id":8011297,"accession":"0000947871-23-000438","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-23-000438","line_url":"/filing/0000947871-23-000438","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; OrbiMed Advisors Israel II Ltd; ORBIMED ADVISORS LLC; OrbiMed Israel GP II, L.P.","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9665.0,"shares_display":"9,665","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":19330.0,"total_display":"19,330.00","total_whole":"19,330","shares_owned_after":2510041.0,"shares_owned_after_display":"2,510,041","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-07","scope":"insider","n_lines":3},{"id":8011288,"accession":"0000947871-23-000438","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000438","line_url":"/filing/0000947871-23-000438#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; OrbiMed Advisors Israel II Ltd; ORBIMED ADVISORS LLC; OrbiMed Israel GP II, L.P.","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63058.0,"shares_display":"63,058","price_per_share":2.18,"price_display":"2.18","price_state":"stated","total_value":137466.44,"total_display":"137,466.44","total_whole":"137,466","shares_owned_after":2516599.0,"shares_owned_after_display":"2,516,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-05","filed_date":"2023-04-07","scope":"insider"},{"id":8011285,"accession":"0000947871-23-000438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-23-000438","line_url":"/filing/0000947871-23-000438#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; OrbiMed Advisors Israel II Ltd; ORBIMED ADVISORS LLC; OrbiMed Israel GP II, L.P.","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25220.0,"shares_display":"25,220","price_per_share":2.18,"price_display":"2.18","price_state":"stated","total_value":54979.6,"total_display":"54,979.60","total_whole":"54,980","shares_owned_after":1006591.0,"shares_owned_after_display":"1,006,591","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-05","filed_date":"2023-04-07","scope":"insider"}],"collapsed":true,"next_cursor":"2023-04-05|8011285","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001720580","name":"Adicet Bio, Inc.","url":"/issuer/0001720580","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2023-06-29","last_seen":"2026-04-09"},{"type":"issuer","type_label":"ISSUER","cik":"0002022626","name":"Upstream Bio, Inc.","url":"/issuer/0002022626","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2024-10-17","last_seen":"2024-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001800315","name":"Galecto, Inc.","url":"/issuer/0001800315","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2020-11-04","last_seen":"2023-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001785173","name":"89bio, Inc.","url":"/issuer/0001785173","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2019-11-13","last_seen":"2022-01-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001664106","name":"LogicBio Therapeutics, Inc.","url":"/issuer/0001664106","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2018-10-25","last_seen":"2020-10-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001619087","name":"SteadyMed Ltd.","url":"/issuer/0001619087","role":"Ten percent owner","n_filings":2,"first_seen":"2017-04-27","last_seen":"2018-09-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001682093","retrieved_at":"2026-08-23T07:52:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}